TXMD
Therapeuticsmd·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
TXMD fundamentals
Therapeuticsmd (TXMD) released its earnings on Nov 12, 2025: revenue was 784.00K (YoY +43.33%), beat estimates; EPS was 0.01 (YoY +120.00%), missed estimates.
Revenue / YoY
784.00K
+43.33%
EPS / YoY
0.01
+120.00%
Report date
Nov 12, 2025
EPS
Revenue
Revenue & Expenses
TXMD has released its 2025 Q3 earnings report, with revenue of 784.00K, reflecting a YoY change of 43.33%, and net profit of 152.00K, showing a YoY change of 124.96%. The Sankey diagram below clearly presents TXMD's revenue sources and cost distribution.
Key Indicators
Therapeuticsmd (TXMD) key financial stats and ratios, covering profitability, financial health, and leverage.
Therapeuticsmd (TXMD)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Therapeuticsmd (TXMD)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Therapeuticsmd (TXMD)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Therapeuticsmd (TXMD) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Therapeuticsmd (TXMD) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from Therapeuticsmd’s earnings call?What is Therapeuticsmd's latest dividend and current dividend yield?What guidance did Therapeuticsmd's management provide for the next earnings period?What factors drove the changes in Therapeuticsmd's revenue and profit?What is Therapeuticsmd's gross profit margin?What is the revenue and EPS growth rate for Therapeuticsmd year over year?What were the key takeaways from Therapeuticsmd's earnings call?What is the market's earnings forecast for Therapeuticsmd next quarter?
